Clinical trial
Centocor Microarray Study of Patients
NCT00462072 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00462072 |
|---|---|
| Title | Centocor Microarray Study of Patients |
| Official title | Microarray Analysis of Peripheral Blood and Tissues of Patients With Immune Mediated Inflammatory Diseases |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Centocor, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis, Crohn's Disease |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 31 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: